Cholinergic Agonists Protect Against Liver Injury from Ischemia-Reperfusion
Author Information
Author(s): Crockett Elahé T, Galligan James J, Uhal Bruce D, Harkema Jack, Roth Robert, Pandya Kinnari
Primary Institution: Michigan State University
Hypothesis
Does pharmacological stimulation of the cholinergic anti-inflammatory pathway protect against liver ischemia-reperfusion injury in mice?
Conclusion
Cholinergic agonists significantly reduce cytokine production and hepatocellular injury during the early phase of liver ischemia-reperfusion.
Supporting Evidence
- Pre-ischemic treatment with DMPP or nicotine significantly decreased plasma ALT levels after 3 hours of reperfusion.
- Histopathology showed reduced hepatocellular injury in treated mice during the early phase of hepatic ischemia-reperfusion.
- Plasma levels of pro-inflammatory cytokines were significantly reduced in mice treated with cholinergic agonists.
Takeaway
Giving certain drugs before liver surgery can help protect the liver from damage caused by lack of blood flow.
Methodology
Adult male mice underwent 90 minutes of partial liver ischemia followed by reperfusion, with treatment using AChR agonists or saline.
Limitations
The protective effect of cholinergic agonists diminished in the late phase of ischemia-reperfusion injury.
Participant Demographics
Adult male C57BL/6 mice, aged 8-10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website